Boston Scientific Corp (XTER:BSX)
€ 86.5 -0.5 (-0.57%) Market Cap: 126.52 Bil Enterprise Value: 134.81 Bil PE Ratio: 74.93 PB Ratio: 6.45 GF Score: 79/100

Boston Scientific Corp at Credit Suisse Healthcare Conference - Scottsdale Transcript

Nov 12, 2019 / 03:00PM GMT
Matthew Stephan Miksic;dit Suisse AG
CrÃ;Research Division - Senior Research Analyst

© -

So good morning. Thanks, everyone, for joining us. My name is Matt Miksic, medical device analyst here at Crédit Suisse. Very pleased to have with us Susie Lisa, Director of Investor Relations, Boston Scientific.

Questions & Answers

Matthew Stephan Miksic;dit Suisse AG
CrÃ;Research Division - Senior Research Analyst

© -

So we'll jump right into questions. There's a number of topics we can cover obviously but I wanted to maybe start with -- the natural thing would be to start with some of the headwinds that came up ahead of the third quarter and how they played out or how you think that they'll play out or how to quantify them. I know the mic here is a little bit noisy. But I'd like to start instead with maybe some of the key highlights from Q3, where you saw areas of momentum, where you saw areas of strength and maybe as we turn the corner into 2020, where you see some of the most significant growth drivers that

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot